Affymetrix
NASDAQ: AFFX
$14.01
+$0.00 (+0.0%)
Closing price April 1, 2016
These biotech companies stood out from the rest with big moves over the course of the past week.
7 years ago
Last Updated: 3 years ago
Affymetrix was absolutely soaring early on Monday on word that it will be acquired. Thermo Fisher Scientific is the buyer.
7 years ago
Last Updated: 3 years ago
In a new research report, Cowen analysts focus on three life science stocks that they think could beat current consensus earnings estimates.
8 years ago
Thursday's top analyst upgrades, downgrades and initiations include Ally FInancial, Apple, Automatic Data Processing, Brocade Communications, Level 3 Communications and Tyco International.
8 years ago
Last Updated: 8 years ago
U.S. equity markets opened lower this morning following a weaker-than-expected employment report from ADP and concern that Friday’s report from the Bureau of Labor Statistics will follow the ADP...
10 years ago
Last Updated: 3 years ago
U.S. equity markets opened mixed this morning as investors weighed conflicting data from the U.S., Europe, and Asia. In Europe, retail sales declined more than expected in Germany, Italy’s...
10 years ago
Last Updated: 3 years ago
Source: Thinkstock24/7 Wall St. has always wondered about the confusing universe of biotech exchange-traded funds (ETFs). Biotech stocks can rise or fall regardless of the market direction, and the...
10 years ago
Last Updated: 10 years ago
Source: Wikimedia Creative Commons, JohnnyMrNinjaThe stock market is down Monday, with the Dow Jones Industrial Average down 0.33%, the Nasdaq down 0.62% and the S&P 500 down 0.46%. Today’s winners...
10 years ago
Last Updated: 3 years ago
What usually happens when you get two mergers announced in drugs and biotech in the same day? Investors begin to wonder which other peers and competitors might be on the M&A block. Monday’s news...
11 years ago
Last Updated: 3 years ago
More biotech mergers are on the way! That is the verdict of Wall St. There may be patent protection risks associated with future regulation under health care, but deals in the biotech and emerging...
11 years ago
Last Updated: 3 years ago
The freshly announced multibillion biotech buyout of Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) for more than $5 billion in equity value may be a bit misleading if you consider that it is...
11 years ago
Last Updated: 3 years ago
Source: Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Monday.Affymetrix Inc. (NASDAQ: AFFX) Cut to Sell at Goldman...
11 years ago
Last Updated: 3 years ago
The three major US stock indexes opened higher this morning as markets ignored a steep rise in short-term Spanish debt and focused instead on some encouraging news on new housing construction permits...
11 years ago
Last Updated: 3 years ago
Source: Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage and research firms this Wednesday morning. Acme Packet, Inc. (NASDAQ: APKT) Cut...
11 years ago
Last Updated: 3 years ago
These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Thursday morning. Affymetrix Inc. (NASDAQ: AFFX) Raised to Neutral from Sell with a...
11 years ago